Pigmentation
Tinted Sunscreen for Melasma: Does Iron Oxide Add Anything to Regular SPF?
Information to help you prepare questions. Treatment suitability, risks and aftercare are assessed individually with the clinic.

Short answer: The British Association of Dermatologists (BAD) says sun cream containing iron oxides "can provide added protection against visible light", and visible light may contribute to melasma. Trials suggest a tinted, iron-oxide sunscreen can help a little more than a UV-only one, but they are small and short, and one of the two trials is industry-funded. A tinted sunscreen is a reasonable part of daily protection. It is not a treatment, and it does not replace getting an uneven mark checked.
If you are weighing up laser pigmentation treatment, this is the groundwork that sits underneath it. Melasma tends to return after treatment stops, so what you put on your face every morning matters.
Why a tint is the point, not a cosmetic extra
Ordinary broad-spectrum sunscreen filters UVB and UVA. Visible light, including high-energy blue-violet light, is a different part of sunlight, and ordinary sunscreens do not adequately block it. A 2021 review in the Journal of the American Academy of Dermatology (Lyons and colleagues) states that mineral filters such as nanoparticle zinc oxide and titanium dioxide do not protect against visible light. The tinted products that do contain iron oxides and pigmentary titanium dioxide. The pigment that gives the colour is what absorbs the light, so a product that does not visibly tint the skin is unlikely to be giving much visible-light protection.
A 2026 narrative review (Ip, Passeron and Rodrigues) describes laboratory work in which blue-violet light stimulates pigment production in melanocytes, and argues visible light is an under-recognised driver of melasma and post-inflammatory pigmentation. It is a review of selected studies, so treat it as a strong hypothesis with supporting data rather than settled fact.
What UK and US guidance says
| Source | What it says | Date |
|---|---|---|
| BAD patient leaflet | SPF 30 or above with a high UVA rating (look for the UVA circle and 5 UVA stars); iron oxides add visible-light protection; wide-brimmed hat; avoid sunbeds; apply 15 to 30 minutes before going out and reapply every two hours outdoors. | Updated June 2024; next review June 2027 |
| BAD, on screens | High-energy visible (blue) light may contribute to melasma, but there is no evidence that blue light from phones or computers affects the skin. | Same leaflet |
| American Academy of Dermatology | Sunscreen with zinc oxide, titanium dioxide or iron oxide is often recommended; a tinted sunscreen may help if a white cast is off-putting. | Updated 15 February 2022 |
| British Skin Foundation | Routine sun protection is rarely necessary in the UK for people with black or dark brown skin, with listed exceptions, but melasma-affected skin darkens more than surrounding skin when exposed to light, so sun avoidance remains important. | Review date not stated on the page |
The last row is worth reading twice. General UK advice for deeper skin tones is that everyday sunscreen is often optional, while melasma is the exception where protection still matters. Which applies to you is a question for your GP, dermatologist or practitioner.
What the trials actually show
Two controlled trials are usually cited. Both have limits you should know about.
- Castanedo-Cazares and colleagues, 2014. 68 people with melasma were randomised to an iron-oxide (UV plus visible-light) sunscreen or a UV-only sunscreen, both SPF 50 or above, for 8 weeks, and 61 completed. Everyone also used 4% hydroquinone. The iron-oxide group improved by 15% more on the melasma severity score (MASI), 28% more on colour measurement and 4% more on melanin measured in skin samples. The authors concluded the visible-light sunscreen enhanced hydroquinone's effect. Limits: small, 8 weeks, and the effect was measured on top of a prescription lightening cream.
- Polena and colleagues, 2025 (a short letter). 42 women with melasma (41 completed) used a tinted, visible-light-protective sunscreen or a similar UV-protective untinted one for 5 months over a summer in southern France. Differences in lightness and colour between melasma and unaffected skin fell significantly in the tinted group but not the untinted group. The clinical score (mMASI) improved in both groups, with no significant difference between them. Limits: funded by the maker of the tinted product, some authors are its employees, and most participants had lighter skin (93% phototype III).
Taken together: the direction of the evidence favours adding visible-light protection, the size of the benefit is modest, and it was not shown to beat a good UV/UVA sunscreen on the clinical score in the more recent trial. Neither trial tells you what concentration of iron oxide is needed.
Reading a label is harder than it should be
A 2026 product analysis (Doan and colleagues) looked at 37 tinted sunscreens sold for hyperpigmentation. 97.3% did not list iron oxide as an active ingredient, only 9.6% of responding brands disclosed iron oxide percentages when contacted (the disclosed range was below 1.4% to 10.4%), and only one of the brands claiming visible-light protection publicly described how it was tested. The authors call for standardised reporting. In practice:
- A visible tint that does not disappear completely when blended is a better sign than a "blue light" claim on the front.
- Iron oxides may appear in the ingredients list under their colour-index names (CI 77491, 77492, 77499). This naming comes from the cosmetic ingredient list convention, not from the trials above.
- An SPF number and a UVA mark tell you about UV protection only. They do not predict visible-light protection.
- The match to your skin shade matters, because a product you will not wear daily protects nothing. A 2026 review notes shade mismatch is a barrier to using visible-light-protective products.
Habits matter as much as the product
The 2026 review by Ip and colleagues reports that fewer than two-thirds of people with hyperpigmentation use sunscreen, and fewer than 10% reapply appropriately. A review by Azevedo and colleagues notes that the amount applied in studies is often lower than the amount that produced the tested protection. BAD advises applying before you go out, reapplying every two hours outdoors, and adding a wide-brimmed hat. A tinted product used thinly and once a day will do less than the trials suggest.
When sunscreen is not enough, or not the right question
- A new or changing mark. BAD advises telling your doctor about any change to a mole or patch of skin. Melasma is a diagnosis, not a guess; the AAD says a dermatologist can tell it from other conditions. See melasma, sun spots or post-inflammatory pigmentation for how they differ.
- Hormones. Pregnancy, the contraceptive pill and HRT are linked to melasma. Do not stop a medicine on your own: see whether the contraceptive pill or HRT can trigger melasma and take the question to your GP.
- Considering laser. Laser can worsen pigmentation or leave lighter patches in melasma, which is why it is treated cautiously. Read melasma laser treatment before a consultation. If marks get darker after any light treatment, see why pigmentation can be darker after laser.
What to bring to a consultation
Note the product you use now and how often you reapply, any prescription or over-the-counter lightening creams, hormonal medicines, and when the marks started or changed. Your practitioner will confirm whether your marks suit any treatment and what sun-protection plan to follow around it.
Frequently asked questions
Is tinted sunscreen better than regular sunscreen for melasma?
It may help a little more. BAD says sun cream containing iron oxides can provide added protection against visible light, and a 2014 trial found modest extra improvement over a UV-only sunscreen when both were used with hydroquinone. A 2025 industry-funded trial found no significant difference in the clinical score between tinted and untinted products, although colour differences narrowed in the tinted group. The evidence is limited, so a tinted product is a reasonable addition rather than a proven fix.
How do I know if a sunscreen contains enough iron oxide?
Currently you often cannot tell. A 2026 analysis found 97.3% of 37 tinted sunscreens did not list iron oxide as an active ingredient and few brands disclosed concentrations. A visible tint and iron oxides in the ingredients list are better signs than a front-of-pack claim. No trial has established the amount needed.
Do I need tinted sunscreen if I have dark skin and live in the UK?
The British Skin Foundation says routine sun protection is rarely necessary in the UK for people with black or dark brown skin, with exceptions. It also says melasma-affected skin darkens more than surrounding skin in light, so avoiding sun exposure still matters. Ask your GP, dermatologist or practitioner what suits you.
Does blue light from my phone cause melasma?
BAD says high-energy visible (blue) light may contribute to melasma but that there is no evidence blue light from personal electronic devices affects the skin. The concern relates to sunlight.
Can sunscreen alone clear melasma?
The sources reviewed do not say so. BAD describes sun protection as one part of management alongside avoiding triggers and treatments, and says melasma often returns after treatment stops. A clinical assessment is the way to find out which options suit your skin.
Ask about pigmentation treatment at Progen
Sources and further information
- BAD: broad-spectrum SPF 30 or above with high UVA rating (5 UVA stars); sun cream containing iron oxides can provide added protection against visible light; high-energy visible (blue) light may contribute to melasma but no evidence that blue light from personal electronic devices affects the skin; wide-brimmed hat; avoid sunbeds; apply 15-30 minutes before and reapply every two hours outdoors; tell your doctor about any change to a mole or patch; laser should be done by a highly experienced operator. Leaflet updated June 2024. Accessed 18 November 2026.
- Routine sun protection is rarely necessary in the UK for people with black or dark brown skin (with listed exceptions); melasma-affected skin darkens more than surrounding skin when exposed to light; no cure and melasma often returns after treatment stops. Accessed 18 November 2026.
- AAD: dermatologists often recommend sunscreens with zinc oxide, titanium dioxide or iron oxide; tinted sunscreen may help if a white cast puts you off; a dermatologist can tell melasma from other conditions. Updated 15 February 2022. Accessed 18 November 2026.
- Lyons et al., JAAD 2021 (PMID 32335182): broad-spectrum sunscreens do not adequately protect against visible light; nanoparticle zinc oxide and titanium dioxide do not; tinted sunscreens with iron oxides and pigmentary titanium dioxide do and are beneficial for hyperpigmentation such as melasma. Abstract read via Europe PMC, accessed 18 November 2026.
- Castanedo-Cazares et al., 2014: 68 randomised, 61 completed, 8 weeks, all on 4% hydroquinone, SPF 50 or above in both arms; iron-oxide group showed 15%, 28% and 4% greater improvement in MASI, colorimetry and melanin; authors conclude UV-VL sunscreen enhances hydroquinone efficacy. Abstract read via Europe PMC, accessed 18 November 2026.
- Polena et al., J Cosmet Dermatol 2025 (PMID 41014037): 42 women (41 completed), 5 months in summer; colour differences between melasma and unaffected skin fell significantly with tinted but not untinted sunscreen; mMASI improved in both groups with no significant difference; funded by NAOS (Bioderma), some authors employees. Open-access full text read via Europe PMC, accessed 18 November 2026.
- Doan et al., J Drugs Dermatol 2026;25(5):440-443 (PMID 42081626): of 37 tinted sunscreens, 97.3% did not list iron oxide as an active; 9.6% of responding brands disclosed concentrations (below 1.4% to 10.4%); only one brand claiming visible-light protection described testing; authors call for standardised reporting. Abstract read via Europe PMC, accessed 18 November 2026.
- Ip, Passeron, Rodrigues, Photodermatol Photoimmunol Photomed 2026;42(5):e70125 (PMID 42802407): visible light, especially 400-450 nm, activates opsin-3 on melanocytes; fewer than two-thirds of people with hyperpigmentation use sunscreen and under 10% reapply appropriately; shade mismatch is a barrier. Abstract read via Europe PMC, accessed 18 November 2026.
- Azevedo, Lorigo, Cairrao, Curr Issues Mol Biol 2026;48(9):921 (PMID 42793277): conventional UVB/UVA protection may not be sufficient; blue light (380-455 nm) linked to hyperpigmentation in skin types IV-VI; iron oxide sunscreens may improve protection; applied amounts in studies often fall below those needed. Abstract read via Europe PMC, accessed 18 November 2026.
More in pigmentation
Questions people ask next
- Rough, Scaly Patch or Age Spot? Why Sun-Damaged Skin Is Checked Before Pigment Laser
- Pigmentation Darker After Laser: Healing Changes or PIH?
- Laser or Chemical Peel for Sun Spots and Age Spots: How They Differ
- Melasma, Sun Spots or Post-Inflammatory Pigmentation?
Treatment details, suitability and booking: pigmentation removal in Bournemouth. All pigmentation guides
Make an informed next step
Bring your questions
to a consultation.
A guide can help you prepare. Your assessment determines which options are appropriate for you.
Continue reading: Laser Skin Rejuvenation, PRP Facial or Polynucleotides?